4//SEC Filing
Jahr Robert Charles 4
Accession 0001415889-25-019586
CIK 0001649989other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 5:17 PM ET
Size
5.6 KB
Accession
0001415889-25-019586
Insider Transaction Report
Form 4
Jahr Robert Charles
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-07-01+800,000→ 800,000 totalExercise: $1.58Exp: 2035-07-01→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on July 1, 2026, with the remaining shares vesting in 36 equal monthly installments over the following three (3) years, subject to the Reporting Person's Continuous Service to the Issuer through each such vesting date.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0002076177
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 5:17 PM ET
- Size
- 5.6 KB